Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | Casein kinase II | 0.5746 | 1 | 1 |
Plasmodium vivax | casein kinase 2, alpha subunit, putative | 0.5746 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.313 | 0.4586 | 0.4586 |
Trichomonas vaginalis | CMGC family protein kinase | 0.5746 | 1 | 1 |
Plasmodium falciparum | casein kinase 2, alpha subunit | 0.5746 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.5746 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.313 | 0.4586 | 0.4586 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.313 | 0.4586 | 0.4586 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.313 | 0.4586 | 0.4586 |
Entamoeba histolytica | casein kinase II regulatory subunit family protein | 0.313 | 0.4586 | 0.4586 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.313 | 0.4586 | 0.4586 |
Trichomonas vaginalis | CMGC family protein kinase | 0.5746 | 1 | 1 |
Onchocerca volvulus | Casein kinase II subunit beta homolog | 0.313 | 0.4586 | 0.5 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.313 | 0.4586 | 0.4586 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.313 | 0.4586 | 0.4586 |
Trichomonas vaginalis | CMGC family protein kinase | 0.5746 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.313 | 0.4586 | 0.4586 |
Plasmodium vivax | unspecified product | 0.5746 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.5746 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.313 | 0.4586 | 0.4586 |
Giardia lamblia | Casein kinase II beta chain | 0.313 | 0.4586 | 0.4586 |
Loa Loa (eye worm) | Csnk2b protein | 0.313 | 0.4586 | 0.4586 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.313 | 0.4586 | 0.4586 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.313 | 0.4586 | 0.4586 |
Giardia lamblia | Kinase, CMGC CK2 | 0.5746 | 1 | 1 |
Entamoeba histolytica | protein kinase domain containing protein | 0.5746 | 1 | 1 |
Echinococcus multilocularis | casein kinase ii subunit alpha | 0.5746 | 1 | 1 |
Leishmania major | casein kinase II, putative | 0.5746 | 1 | 1 |
Entamoeba histolytica | casein kinase, putative | 0.5746 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.313 | 0.4586 | 0.4586 |
Trichomonas vaginalis | CMGC family protein kinase | 0.5746 | 1 | 1 |
Entamoeba histolytica | casein kinase II regulatory subunit family protein | 0.313 | 0.4586 | 0.4586 |
Onchocerca volvulus | Casein kinase II subunit beta homolog | 0.313 | 0.4586 | 0.5 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.313 | 0.4586 | 0.4586 |
Trichomonas vaginalis | CMGC family protein kinase | 0.5746 | 1 | 1 |
Echinococcus granulosus | casein kinase ii subunit alpha | 0.5746 | 1 | 1 |
Loa Loa (eye worm) | CMGC/CK2 protein kinase | 0.5746 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.313 | 0.4586 | 0.4586 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.313 | 0.4586 | 0.4586 |
Brugia malayi | Csnk2b protein | 0.313 | 0.4586 | 0.4586 |
Schistosoma mansoni | protein kinase | 0.5746 | 1 | 1 |
Toxoplasma gondii | CMGC kinase, CK2 family | 0.5746 | 1 | 1 |
Trypanosoma cruzi | casein kinase II, putative | 0.5746 | 1 | 1 |
Entamoeba histolytica | casein kinase II regulatory subunit family protein | 0.313 | 0.4586 | 0.4586 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ID50 (functional) | = 0.16 ug kg-1 | Inhibitory activity against Bezold-jarisch functional assay, inducing a transient bradicardia upon intravenous administration of 5-hydroxytryptamine(10 ug/kg) in anesthetized rats. | ChEMBL. | 1527780 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.